Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 17/20 | 0.69 |
| ▸ | PPARG | P37231 | 13/20 | 0.69 |
| ▸ | PPARD | Q03181 | 6/20 | 0.69 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1670312 | 1.00 | PPARA (0.69) | PPARAPPARGPPARDSRR | |
| SCHEMBL15246753 | 0.87 | PPARA (0.56) | PPARAPPARGPPARDSRR | |
| Ethylene SCHEMBL5331457 | 0.87 | PPARA (0.65) | PPARAPPARGPPARDSRR | |
| SCHEMBL16415813 | 0.87 | PPARA (0.92) | PPARAPPARGPPARD | |
| SCHEMBL5993963 | 0.87 | PPARA (0.92) | PPARAPPARGPPARD | |
| SCHEMBL5608022 | 0.87 | PPARA (0.92) | PPARAPPARGPPARD | |
| SCHEMBL543815 | 0.86 | PPARA (0.72) | PPARAPPARGPPARD | |
| SCHEMBL17680422 | 0.86 | PPARA (0.68) | PPARAPPARGPPARD | |
| SCHEMBL3541115 | 0.86 | MMP8 (0.56) | PPARAPPARGPPARDSRR | |
| SCHEMBL5543269 | 0.86 | PPARA (0.72) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
| US-20080114064-A1 | Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid | ASTRAZENECA AB (SE) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | GLUL, GATD3, GLS | PPARA 1857/4885PPARG 1211/4885PPARD 1270/4885 |
| US-20080114064-A1 | Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid | PNMT, TET3, TET1 | PPARA 1083/4885PPARG 2420/4885PPARD 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.